在儿童B型急性淋巴细胞白血病中的双特异性T细胞参与者
Kaylyn Utley Lyons1, Lia Gore2
1Children's Hospital Colorado.
Haematologica
|June 4, 2024
概括
双特异性T细胞参与剂 (BiTEs),如blinatumomab,为治疗儿童癌症,特别是B细胞急性淋巴细胞白血病 (B-ALL) 提供了新的希望. 这些免疫疗法实现了深度缓解,并显示毒性降低,为未来的儿科癌症治疗铺平了道路.
科学领域:
- 儿科瘤学 儿科瘤学
- 免疫治疗是一种免疫疗法.
- 血液学恶性瘤是什么
背景情况:
- 免疫疗法改变了癌症护理,但在儿童癌症中应用有限.
- 双特异性T细胞参与剂 (BiTEs) 和CAR T细胞疗法正在成为对抗耐药儿科恶性瘤的强大工具.
- 布利纳图莫马布是一种CD3-CD19BiTE,对儿童的前体B型急性淋巴细胞白血病 (B-ALL) 和淋巴细胞淋巴瘤的治疗产生了重大影响.
研究的目的:
- 审查临床试验和关于小儿恶性瘤中的布利纳图莫巴的文献.
- 讨论BiTE在更广泛的儿科癌症群体中的潜力.
- 探索未来的治疗策略和组合试验,涉及儿童B-ALL的BTE.
主要方法:
- 关于blinatumomab的相关临床试验文献的审查.
- 对儿科患者用布利纳马布的疗效和毒性数据的分析.
- 探索新兴的组合疗法和BTE的未来方向.
主要成果:
- 在一些儿科B-ALL患者中,BLINATUMOMAB已经证明成功地实现了分子负性疾病状态和长期缓解.
- 与传统治疗相比,这种治疗与毒性降低有关.
- 布利纳图莫马布也在治疗淋巴细胞淋巴瘤方面表现出潜力.
结论:
- 布利纳莫马布在治疗儿童B-ALL方面取得了重大进展,提供了改善的结果和降低的毒性.
- 布利纳图马布的成功表明,它在未来的儿科B-ALL治疗模式中起着至关重要的作用.
- 对于儿科恶性瘤,需要对组合试验和BTE的更广泛应用进行进一步的研究.
相关概念视频
B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Special Features of Adaptive Immunity
802
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
802
T Cell Activation and Clonal Selection
706
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
706
Cells of the Adaptive Immune Response
980
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
980


